ArticleResearch square2025
Capturing Unanticipated Drug Toxicities Using an Ensemble Machine Learning Approach.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Despite rigorous safety evaluations during development, numerous drugs have been withdrawn from the market due to serious toxicities. Here we investigate the features found in drugs with these unanticipated toxicities and apply a machine learning approach to predict if a drug is likely to be withdrawn due to intolerable side effects without the need for human trial data. Our best preforming classifier was an ensemble predictor trained on protein targets, protein structure features, chemical fingerprints, and chemical features that achieved 92% accuracy and 0.845 Matthews Correlation Coefficient with 10-fold holdout test set cross validation. Analysis of features predictive of unanticipated toxicity revealed both known factors such as inhibition of cytochrome P450 as well as yet uninvestigated factors including the inhibition of bile salt export pumps. This predictor and subsequent feature analysis pave the way for the larger role of computational methods in screening potential candidates during drug development.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.